Grants and Contributions:
Title:
EMR2EDC: Clinical-trial Sponsor Platform
Agreement Number:
948065
Agreement Value:
$249,569.00
Agreement Date:
Apr 1, 2020 - Mar 31, 2021
Description:
This project concerns the development and design-verification (both in-house and in-field) of a new clinical-trial sponsor platform.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V5Y 3W2
Reference Number:
172-2020-2021-Q1-948065
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
894981414
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 59 days.
Amendment Date
Jan 7, 2021
Recipient's Legal Name:
Equicare Health Inc
Federal Riding Name:
Vancouver Granville
Federal Riding Number:
59036
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541514
Amendments: